We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Events

02 Jun 2025 - 04 Jun 2025
11 Jun 2025 - 13 Jun 2025

Unique AI-Based Approach Automates Clinical Analysis of Blood Data

By LabMedica International staff writers
Posted on 19 Jul 2023

The clinical analysis of blood data, known as cytometry, is a labor-intensive process that is largely subjective, even for the most skilled laboratory staff. More...

Current cytometry-based diagnostics for blood cancer and other immune diseases require doctors and analysts to evaluate complex, high-dimensional data sets. This analysis, which averages around 20 minutes per sample, is not only time-consuming but also faces a significant shortage of trained personnel. Moreover, the process is quite subjective, with approximately 30% variability in analysis between different operators. These challenges have limited the use of cytometry data for more personalized treatment. Now, a cloud-based machine learning platform can help labs manage their caseloads, provide an objective second opinion to every patient, and offer new insights to physicians for tailoring treatments to every patient's unique immune system.

hema.to (Munich, Germany) offers user-friendly software for clinical decision support in blood cancer cases using cytometry data. This artificial intelligence (AI)-powered tool, which is FDA registered and has CE-IVD approval, streamlines the diagnostic workflow, benefiting both diagnosticians and patients. Already implemented in leading hematology labs, the AI software is now being scaled up to support blood cancer diagnostics in laboratories across Europe and demonstrate significant improvements in diagnostic quality.

hema.to's proprietary algorithms, developed using its extensive and continuously growing database of diverse cytometry data sources, can predict disease biomarkers directly from the raw data generated by blood measurement devices. This addresses a hitherto unresolved issue caused by the lack of standardized measurement protocols, resulting in complex data variability that previously hampered automation. The company specializes in integrating data from various sources to identify predictive disease biomarkers. This technology has already been incorporated into the regular clinical workflow of two German labs for decision support. hema.to now plans to broaden its user base, expand the range of supported diseases, and enhance the quality of its AI models.

“Europe’s largest leukemia lab had the real need to speed-up their internal analysis workflows and worked with us to build a world-first AI prototype,” said Karsten Miermans, co-founder and CEO of hema.to. After the success of demonstration of AI-assisted clinical cytometry, we noticed that all labs have the same manual workflows and pain points. We founded hema.to two years ago to help labs across the world with their clinical cytometry workflows.”

Related Links:
hema.to 


New
Gold Member
Thyroid-Stimulating Hormone Test
ULTRA-TSH
Gold Member
Troponin T QC
Troponin T Quality Control
New
Glucose Tolerance Test
NERL Trutol
New
Droplet Digital PCR System
QX600 AutoDG
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: New biomarkers could someday make it easy to spot Parkinson’s disease in a patient’s blood sample (Photo courtesy of Shutterstock)

Unique Blood-Based Genetic Signature Can Diagnose Parkinson’s Disease

Parkinson's disease is primarily recognized for its impact on the central nervous system. Recent scientific progress has shifted focus to understanding the involvement of the immune system in the onset... Read more

Immunology

view channel
Image: Custom hardware and software for the real-time detection of immune cell biophysical signatures in NICU (Photo courtesy of Pediatric Research, DOI:10.1038/s41390-025-03952-y)

First-Of-Its-Kind Device Profiles Newborns' Immune Function Using Single Blood Drop

Premature infants are highly susceptible to severe and life-threatening conditions, such as sepsis and necrotizing enterocolitis (NEC). Newborn sepsis, which is a bloodstream infection occurring in the... Read more

Pathology

view channel
Image: The new tool is designed for accurate detection of structural variations in clinical samples (Photo courtesy of Karen Arnott/EMBL-EBI and Isabel Romero Calvo/EMBL)

ML Algorithm Accurately Identifies Cancer-Specific Structural in Long-Read DNA Sequencing Data

Long-read sequencing technologies are designed to analyze long, continuous stretches of DNA, offering significant potential to enhance researchers' abilities to detect complex genetic changes in cancer genomes.... Read more

Technology

view channel
Image: Concept of biosensor integrated into hygiene pads enabling direct semi-quantitative analysis of biomarkers in unprocessed menstruation blood (Photo courtesy of Dosnon, L et al. DOI: 10.1002/advs.202505170)

First Ever Technology Recognizes Disease Biomarkers Directly in Menstrual Blood in Sanitary Towels

Over 1.8 billion people menstruate worldwide, yet menstrual blood has been largely overlooked in medical practice. This blood contains hundreds of proteins, many of which correlate with their concentration... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.